Showing results (51-60 of 392) with videos related to

Sort By:
Pageof 40
Blood|March 8, 2012
Risk categories and refractory CLL in the era of chemoimmunotherapyThorsten Zenz, John G Gribben, Michael Hallek, et al.
The Journal of Experimental Medicine|October 24, 2012
Cellular origin and pathophysiology of chronic lymphocytic leukemiaMarc Seifert, Ludger Sellmann, Johannes Bloehdorn, et al.
Blood|January 26, 2013
Lenalidomide reduces survival of chronic lymphocytic leukemia cells in primary cocultures by altering the myeloid microenvironmentAngela Schulz, Claudia Dürr, Thorsten Zenz, et al.
Nucleic Acids Research|January 16, 2003
Capillary electrophoretic analysis of genomic DNA methylation levelsDirk Stach, Oliver J Schmitz, Stephan Stilgenbauer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 26, 2006
Antagonizing inactivated tumor suppressor genes and activated oncogenes by a versatile transgenesis system: application in mantle cell lymphomaArmin Pscherer, Julia Schliwka, Kathrin Wildenberger, et al.
Haematologica|November 17, 2018
<i>TP53</i> aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnosticsElias Campo, Florence Cymbalista, Paolo Ghia, et al.
Blood|December 13, 2003
The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the VH gene mutational statusPeter Dreger, Stephan Stilgenbauer, Axel Benner, et al.
Leukemia & Lymphoma|July 16, 2013
Extracellular vesicles in chronic lymphocytic leukemiaFranziska Haderk, Bola Hanna, Karsten Richter, et al.
Leukemia & Lymphoma|November 4, 2009
BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemiaThorsten Zenz, Axel Benner, Ulrich Dührsen, et al.
Molecular and Clinical Oncology|December 15, 2021
Cost-effectiveness of precision cancer medicine-current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical utility frameworks (Review)Konstantinos Christofyllakis, Joerg Thomas Bittenbring, Lorenz Thurner, et al.
Pageof 40